OXFORD MEDICAL SIMULATION LIMITED

Active London

Business and domestic software development

54 employees website.com
Healthcare and wellbeing Business and domestic software development
O

OXFORD MEDICAL SIMULATION LIMITED

Business and domestic software development

Founded 27 Jan 2017 Active London, England 54 employees website.com
Healthcare and wellbeing Business and domestic software development
Accounts Submitted 9 Oct 2025 Next due 31 Oct 2026 5 months remaining
Confirmation Submitted 27 Jan 2026 Next due 10 Feb 2027 8 months remaining
Net assets £10M £8M 2023 year on year
Total assets £13M £9M 2023 year on year
Total Liabilities £3M £211K 2023 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

201 Borough High Street London SE1 1JA England

Email

info@example.com

Website

www.example.com

Full company profile for OXFORD MEDICAL SIMULATION LIMITED (10587122), an active healthcare and wellbeing company based in London, England. Incorporated 27 Jan 2017. Business and domestic software development. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

£8.91M

Increased by £7.88M (+771%)

Net Assets

£10.26M

Increased by £8.40M (+453%)

Total Liabilities

£3.02M

Increased by £210.68k (+7%)

Turnover

N/A

Employees

54

Increased by 18 (+50%)

Debt Ratio

23%

Decreased by 37 (-62%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 4Oct 2018Seed
Investor 1Oct 2022Series A
Investor 3Oct 2022Series A

Share Capital

Share Capital

Share allotments and capital structure

18 Allotments 198,879 Shares £19.93m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Jan 20246,688£817k£122.15
22 Dec 20236,140£750k£122.15
23 Nov 202361,696£7.54m£122.15
23 Nov 20237,412£905k£122.15
16 Jun 202211,807£1.00m£84.7

Officers

Officers

2 active 1 resigned
Status
Fabio Nicola Raffaele MorandiDirectorItalianEngland518 Aug 2018Active
Steven Michael DunneDirectorBritishEngland5711 Dec 2024Active

Shareholders

Shareholders (45)

Mr Leslie Ronald Hurst
17.3%
59,221
Frog European Growth Ii Lp Acting By Its General Partner Feg Ii Gp S.a.r.l., Represented By Frog Capital Limited
16.7%
57,307

Persons with Significant Control

Persons with Significant Control (0)

0 Active 5 Ceased

Michael William Lyon Wallace

Ceased 18 Nov 2020

Ceased

Jack Pottle

Ceased 18 Nov 2020

Ceased

Leslie Ronald Hurst

Ceased 18 Nov 2020

Ceased

Michael William Lyon Wallace

Ceased 29 Mar 2019

Ceased

Jack Pottle

Ceased 29 Mar 2019

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Jan 2026Confirmation StatementConfirmation statement made on 27 Jan 2026 with updates
5 Jan 2026OfficersChange to director Dr Klaus Nicolaus Peter Henke on 1 Dec 2025
22 Dec 2025OfficersTermination of Terence Hancock as director on 19 Dec 2025
19 Dec 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
29 Oct 2025OfficersChange to director Dr Klaus Nicolaus Peter Henke on 14 Apr 2025
27 Jan 2026 Confirmation Statement

Confirmation statement made on 27 Jan 2026 with updates

5 Jan 2026 Officers

Change to director Dr Klaus Nicolaus Peter Henke on 1 Dec 2025

22 Dec 2025 Officers

Termination of Terence Hancock as director on 19 Dec 2025

19 Dec 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

29 Oct 2025 Officers

Change to director Dr Klaus Nicolaus Peter Henke on 14 Apr 2025

Recent Activity

Latest Activity

Confirmation statement made on 27 Jan 2026 with updates

3 months ago on 27 Jan 2026

Change to director Dr Klaus Nicolaus Peter Henke on 1 Dec 2025

4 months ago on 5 Jan 2026

Termination of Terence Hancock as director on 19 Dec 2025

4 months ago on 22 Dec 2025

Mortgage Create With Deed With Charge Number Charge Creation Date

5 months ago on 19 Dec 2025

Change to director Dr Klaus Nicolaus Peter Henke on 14 Apr 2025

6 months ago on 29 Oct 2025